Natera, Inc.
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera BGI Genomics License Agreement by Year
BGI Genomics License Agreement — Current Contract Liability ($M) [legacy through Q3 2025] ($M)
Natera BGI Genomics License Agreement: $0.50M in FY2024, down 58.3% from a year earlier. No newer figure appears in the documents we track.
Where the FY2024 figure comes from
Source: Form 10-K (2025-02-28) ↗
Reported in Form 10-K/10-Q Note — Collaborative & Licensing Arrangements (2019–2025Q3).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | BGI Genomics License Agreement — Current Contract Liability ($M) [legacy through Q3 2025] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0.50 | -58.3% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 1.20 | +1,100.0% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 0.10 | -96.9% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 3.20 | -17.9% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 3.90 | – | Form 10-K (2021-02-26) ↗ |
Cite this data
StockData. (2026). Natera BGI Genomics License Agreement ($M), annual FY2020–FY2024 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/contract-liab-bgi-current
See every metric in the Natera KPI table. Data updated Nov 2, 2026.